Erratum: 2019 Update to: Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (Diabetes Care, (2020) 43, (487-493), 10.2337/dci19-0066)

J. B. Buse; D. J. Wexler; A. Tsapas; P. Rossing; Geltrude Mingrone; C. Mathieu; D. A. D'alessio; M. J. Davies

doi:10.2337/dc20-er07

Erratum: 2019 Update to: Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (Diabetes Care, (2020) 43, (487-493), 10.2337/dci19-0066)

J. B. Buse
, D. J. Wexler
, A. Tsapas
, P. Rossing
, Geltrude Mingrone
, C. Mathieu
, D. A. D'alessio
, M. J. Davies

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

The incorrect figure legend was printed for Figure 2. The first sentence of the legend should read as follows: “Choosing glucose-lowering medication in those with indicators of high-risk or established atherosclerotic cardiovascular disease (ASCVD), chronic kidney disease (CKD), or heart failure (HF).” The online version of the article (https://doi.org/10.2337/dci19-0066) has been updated to correct this error.

Lingua originale	Inglese
pagine (da-a)	1670-1670
Numero di pagine	1
Rivista	Diabetes Care
Volume	43
Numero di pubblicazione	7
DOI	https://doi.org/10.2337/dc20-er07
Stato di pubblicazione	Pubblicato - 2020

All Science Journal Classification (ASJC) codes

Medicina Interna
Endocrinologia, Diabete e Metabolismo
Infermieristica Avanzata e Specializzata

Keywords

HYPERGLYCAEMIA
TYPE 2 DIABETES

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.2337/dc20-er07

Altri file e collegamenti

Fingerprint

Entra nei temi di ricerca di 'Erratum: 2019 Update to: Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (Diabetes Care, (2020) 43, (487-493), 10.2337/dci19-0066)'. Insieme formano una fingerprint unica.

Cita questo

Buse, J. B., Wexler, D. J., Tsapas, A., Rossing, P., Mingrone, G., Mathieu, C., D'alessio, D. A., & Davies, M. J. (2020). Erratum: 2019 Update to: Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (Diabetes Care, (2020) 43, (487-493), 10.2337/dci19-0066). Diabetes Care, 43(7), 1670-1670. https://doi.org/10.2337/dc20-er07

Buse, J. B. ; Wexler, D. J. ; Tsapas, A. et al. / Erratum: 2019 Update to: Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (Diabetes Care, (2020) 43, (487-493), 10.2337/dci19-0066). In: Diabetes Care. 2020 ; Vol. 43, N. 7. pagg. 1670-1670.

@article{3f4e5fd0bb7a49cfa0a5079ee3d40a70,

title = "Erratum: 2019 Update to: Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (Diabetes Care, (2020) 43, (487-493), 10.2337/dci19-0066)",

abstract = "The incorrect figure legend was printed for Figure 2. The first sentence of the legend should read as follows: “Choosing glucose-lowering medication in those with indicators of high-risk or established atherosclerotic cardiovascular disease (ASCVD), chronic kidney disease (CKD), or heart failure (HF).” The online version of the article (https://doi.org/10.2337/dci19-0066) has been updated to correct this error.",

keywords = "HYPERGLYCAEMIA, TYPE 2 DIABETES, HYPERGLYCAEMIA, TYPE 2 DIABETES",

author = "Buse, \{J. B.\} and Wexler, \{D. J.\} and A. Tsapas and P. Rossing and Geltrude Mingrone and C. Mathieu and D'alessio, \{D. A.\} and Davies, \{M. J.\}",

year = "2020",

doi = "10.2337/dc20-er07",

language = "English",

volume = "43",

pages = "1670--1670",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association:National Service Center, 1701 North Beaureguard Street:Alexandria, VA 22311:(800)232-3472, (703)549-1500, INTERNET: http://www.diabetes.org/diabetscare, Fax: (703)549-6995",

number = "7",

}

Buse, JB, Wexler, DJ, Tsapas, A, Rossing, P, Mingrone, G, Mathieu, C, D'alessio, DA & Davies, MJ 2020, 'Erratum: 2019 Update to: Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (Diabetes Care, (2020) 43, (487-493), 10.2337/dci19-0066)', Diabetes Care, vol. 43, n. 7, pagg. 1670-1670. https://doi.org/10.2337/dc20-er07

Erratum: 2019 Update to: Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (Diabetes Care, (2020) 43, (487-493), 10.2337/dci19-0066). / Buse, J. B.; Wexler, D. J.; Tsapas, A. et al.
In: Diabetes Care, Vol. 43, N. 7, 2020, pag. 1670-1670.

Risultato della ricerca: Contributo in rivista › Articolo

TY - JOUR

T1 - Erratum: 2019 Update to: Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (Diabetes Care, (2020) 43, (487-493), 10.2337/dci19-0066)

AU - Buse, J. B.

AU - Wexler, D. J.

AU - Tsapas, A.

AU - Rossing, P.

AU - Mingrone, Geltrude

AU - Mathieu, C.

AU - D'alessio, D. A.

AU - Davies, M. J.

PY - 2020

Y1 - 2020

N2 - The incorrect figure legend was printed for Figure 2. The first sentence of the legend should read as follows: “Choosing glucose-lowering medication in those with indicators of high-risk or established atherosclerotic cardiovascular disease (ASCVD), chronic kidney disease (CKD), or heart failure (HF).” The online version of the article (https://doi.org/10.2337/dci19-0066) has been updated to correct this error.

AB - The incorrect figure legend was printed for Figure 2. The first sentence of the legend should read as follows: “Choosing glucose-lowering medication in those with indicators of high-risk or established atherosclerotic cardiovascular disease (ASCVD), chronic kidney disease (CKD), or heart failure (HF).” The online version of the article (https://doi.org/10.2337/dci19-0066) has been updated to correct this error.

KW - HYPERGLYCAEMIA

KW - TYPE 2 DIABETES

KW - HYPERGLYCAEMIA

KW - TYPE 2 DIABETES

UR - https://publicatt.unicatt.it/handle/10807/203298

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85086792891&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85086792891&origin=inward

U2 - 10.2337/dc20-er07

DO - 10.2337/dc20-er07

M3 - Article

SN - 0149-5992

VL - 43

SP - 1670

EP - 1670

JO - Diabetes Care

JF - Diabetes Care

IS - 7

ER -

Buse JB, Wexler DJ, Tsapas A, Rossing P, Mingrone G, Mathieu C et al. Erratum: 2019 Update to: Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (Diabetes Care, (2020) 43, (487-493), 10.2337/dci19-0066). Diabetes Care. 2020;43(7):1670-1670. doi: 10.2337/dc20-er07